In vitro characterization, evaluation of enzymatic activity and capacity of intestinal absorption of daogest (Dao extract from pig kidney)
The objective of this study was to assess the capability of a DAO extract (DAOgest) to degrade histamine and to determine its absorption potential. (Source: Clinical Nutrition ESPEN)
Source: Clinical Nutrition ESPEN - December 1, 2023 Category: Nutrition Authors: P. Galvez-Martin, E. Gallego, L. Solano-Roman í, D. Martínez-Puig, J. Cabañas, G. Castells, J. Velasco Source Type: research
An open-label, randomised, controlled trial on the benefit of hmb, L-arginine, and L-glutamine beverages and locomotion training as supportive care in the treatment of unresectable advanced hepatocellular carcinoma using lenvatinib: Hello study
In this study, we report a randomised, controlled trial (RCT) on the efficacy of HMB/L-arginine/L-glutamine (HMB/Arg/Gln) and locomotion training as supportive care in the treatment of unresectable advanced HCC with lenvatinib. (Source: Clinical Nutrition ESPEN)
Source: Clinical Nutrition ESPEN - December 1, 2023 Category: Nutrition Authors: A. Naganuma, F. Makita, R. Sugimoto, M. Kikuchi, K. Furuta, S. Iwamoto, E. Mita, H. Kouno, K. Ario, H. Yatsuhashi, National Hospital Organization Liver Disease Network Group Source Type: research
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19
CONCLUSIONS: Low-certainty evidence suggests nirmatrelvir/ritonavir reduces the risk of all-cause mortality and hospital admission or death in high-risk, unvaccinated COVID-19 outpatients infected with the Delta variant of SARS-CoV-2. There is low- to moderate-certainty evidence of the safety of nirmatrelvir/ritonavir. Very low-certainty evidence exists regarding the effects of nirmatrelvir/ritonavir on all-cause mortality and viral clearance in mildly to moderately affected, mostly unvaccinated COVID-19 inpatients infected with the Omicron variant of SARS-CoV-2. Insufficient and inconsistent information prevents the asses...
Source: Cochrane Database of Systematic Reviews - November 30, 2023 Category: General Medicine Authors: Stefanie Reis Maria-Inti Metzendorf Rebecca Kuehn Maria Popp Ildiko Gagyor Peter Kranke Patrick Meybohm Nicole Skoetz Stephanie Weibel Source Type: research
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19
CONCLUSIONS: Low-certainty evidence suggests nirmatrelvir/ritonavir reduces the risk of all-cause mortality and hospital admission or death in high-risk, unvaccinated COVID-19 outpatients infected with the Delta variant of SARS-CoV-2. There is low- to moderate-certainty evidence of the safety of nirmatrelvir/ritonavir. Very low-certainty evidence exists regarding the effects of nirmatrelvir/ritonavir on all-cause mortality and viral clearance in mildly to moderately affected, mostly unvaccinated COVID-19 inpatients infected with the Omicron variant of SARS-CoV-2. Insufficient and inconsistent information prevents the asses...
Source: Cochrane Database of Systematic Reviews - November 30, 2023 Category: General Medicine Authors: Stefanie Reis Maria-Inti Metzendorf Rebecca Kuehn Maria Popp Ildiko Gagyor Peter Kranke Patrick Meybohm Nicole Skoetz Stephanie Weibel Source Type: research
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19
CONCLUSIONS: Low-certainty evidence suggests nirmatrelvir/ritonavir reduces the risk of all-cause mortality and hospital admission or death in high-risk, unvaccinated COVID-19 outpatients infected with the Delta variant of SARS-CoV-2. There is low- to moderate-certainty evidence of the safety of nirmatrelvir/ritonavir. Very low-certainty evidence exists regarding the effects of nirmatrelvir/ritonavir on all-cause mortality and viral clearance in mildly to moderately affected, mostly unvaccinated COVID-19 inpatients infected with the Omicron variant of SARS-CoV-2. Insufficient and inconsistent information prevents the asses...
Source: Cochrane Database of Systematic Reviews - November 30, 2023 Category: General Medicine Authors: Stefanie Reis Maria-Inti Metzendorf Rebecca Kuehn Maria Popp Ildiko Gagyor Peter Kranke Patrick Meybohm Nicole Skoetz Stephanie Weibel Source Type: research
